메뉴 건너뛰기




Volumn 45, Issue 11, 2005, Pages 867-869

Aβ vaccine therapy for Alzheimer's disease

Author keywords

Amyloid protein; Anti A antibody; APP transgenic mouse; Senile plaques; Vaccine

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN VACCINE; FREUND ADJUVANT; UNCLASSIFIED DRUG; VIRUS VECTOR;

EID: 31544482664     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (1)

References (9)
  • 1
    • 0037135111 scopus 로고    scopus 로고
    • The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
    • Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-356
    • (2002) Science , vol.297 , pp. 353-356
    • Hardy, J.1    Selkoe, D.J.2
  • 2
    • 0036853548 scopus 로고    scopus 로고
    • Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease
    • Hock C, Konietzko U, Papassotiropoulos A, et al: Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease. Nat Med 2002; 8: 1270-1275
    • (2002) Nat Med , vol.8 , pp. 1270-1275
    • Hock, C.1    Konietzko, U.2    Papassotiropoulos, A.3
  • 3
    • 0035902619 scopus 로고    scopus 로고
    • Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
    • DeMattos RB, Bales KR, Cummins DJ, et al: Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2001; 98: 8850-8855
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 8850-8855
    • DeMattos, R.B.1    Bales, K.R.2    Cummins, D.J.3
  • 4
    • 0041886776 scopus 로고    scopus 로고
    • Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease
    • Monsonego A, Zota V, Karni A, et al: Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease. J Clin Invest 2003; 112: 415-422
    • (2003) J Clin Invest , vol.112 , pp. 415-422
    • Monsonego, A.1    Zota, V.2    Karni, A.3
  • 5
    • 0033536163 scopus 로고    scopus 로고
    • Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
    • Schenk D, Barbour R, Dunn W, et al: Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173-177
    • (1999) Nature , vol.400 , pp. 173-177
    • Schenk, D.1    Barbour, R.2    Dunn, W.3
  • 6
    • 20944448555 scopus 로고    scopus 로고
    • Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
    • Gilman S, Koller M, Black RS, et al: Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial. Neurology 2005; 64: 1553-1562
    • (2005) Neurology , vol.64 , pp. 1553-1562
    • Gilman, S.1    Koller, M.2    Black, R.S.3
  • 7
    • 0037393454 scopus 로고    scopus 로고
    • Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: A case report
    • Nicoll JAR, Wilkinson D, Holmes C, et al: Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat Med 2003; 9: 448-452
    • (2003) Nat Med , vol.9 , pp. 448-452
    • Nicoll, J.A.R.1    Wilkinson, D.2    Holmes, C.3
  • 8
    • 0033835996 scopus 로고    scopus 로고
    • Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
    • Bard F, Cannon C, Barbour R, et al: Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000; 6: 916-919
    • (2000) Nat Med , vol.6 , pp. 916-919
    • Bard, F.1    Cannon, C.2    Barbour, R.3
  • 9
    • 14244252864 scopus 로고    scopus 로고
    • Development of a safe oral Aβ vaccine using recombinant adeno-associated virus vector for Alzheimer's disease
    • Hara H, Monsonego A, Yuasa K, et al: Development of a safe oral Aβ vaccine using recombinant adeno-associated virus vector for Alzheimer's disease. J Alz Dis 2004; 5: 483-488
    • (2004) J Alz Dis , vol.5 , pp. 483-488
    • Hara, H.1    Monsonego, A.2    Yuasa, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.